HCEMM logo

Presentations

Immuno-inflammatory Diseases

Edit Buzás, HCEMM-SU Extracellular Vesicles Research Group

  • Edit Buzás: Microvesicles in health and disease..
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 12. 2021.

Prof. András Dinnyés, HCEMM-USZ StemCell Research Group

  • András Dinnyés: Genetikailag újraprogramozott őssejtek felhasználása a regenerációs medicina területén.
    Project Management Institute Budapest, Hungarian Chapter “Lunch & Learn Webinar” c. rendezvényén, Hungary, 5. 2022.
  • András Dinnyés: Disznószív átültetés emberbe. Kutatás az “örök fiatalságért”.
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “Kerengő” c. műsorában, Hungary, 4. 2022.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Heti TV “Heti Jégbüfé” c. műsorában, Hungary, 2. 2022.
  • András Dinnyés: .
    Dr. Dinnyés András előadása az ELTE Radnóti Miklós Gyakorlóiskola X Hischool Pályaválasztási Fesztiválon, Hungary, 1. 2022.
  • András Dinnyés: A meghalt kutyákat már több helyen klónozzák – De milyen lesz a másolat házikedvenc?.
    Tudás.hu online cikkben interjú , Hungary, 1. 2022.
  • András Dinnyés: Sertésszív ültetése emberbe, xenotranszplantáció.
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, 1. 2022.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HiScool Alapítvány által szervezett pályaorientációs nap alkalmából, Hungary, 12. 2021.
  • András Dinnyés: Mesterségesen létrehozott szövetek és szervek őssejtekből- A regenerációs orvoslás lehetőségei.
    Előadás. Civil Közösségi Ház , Gödöllő, Hungary, 11. 2021.
  • András Dinnyés: Stem cell biology in basic research and diseases.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.
  • Veréb Zoltán: Cell-based therapies: advanced therapy medicinal products.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.
  • András Dinnyés: Modelling Alzheimer’s disease pathology through multilineage differentiation of disease-specific human induced pluripotent stem cells.
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, 10. 2021.
  • András Dinnyés: Regenerative medicine solutions for type 1 diabetes: The iNanoBit project.
    BIOCEV Regeneration 1Vestec, Vestec, Czech Republic, 9. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a HírTV “Radar” c. műsorában, Hungary, 9. 2021.
  • András Dinnyés: Dolly, a ballerina.
    Online cikkben interjú: Magyar Nemzet (Lugas rovat) , Hungary, 7. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Laikus TV “Kódolatlan” c. műsorában, Hungary, 7. 2021.
  • András Dinnyés: New approach methods (NAMs) for developmental neurotoxicology using human iPSC-derived 2D and 3D neuronal models. .
    Advanced Organotypic Models for Toxicological Screening, , 5. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Kossuth Rádió “Felfedező” c. műsorában, Hungary, 4. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Klubrádió “Utópia” c. Műsorában, Hungary, 3. 2021.
  • András Dinnyés: .
    Interjú Dr. Dinnyés Andrással a Magyar Katolikus Rádió “A héten történt – Előtérben a háttér” c. műsorában, Hungary, 3. 2021.
  • András Dinnyés: .
    Kerekasztal beszelgetes Dinnyés Andrással a CEU “Határtalan Tudás” c. rendezvényén, Hungary, 2. 2021.
  • András Dinnyés: Van, aki még a vakcinákat is elutasítja, nemhogy egy sertésszívet.
    Qubit online cikkben interjú, Hungary, 2. 2021.
  • András Dinnyés: Génszerkeszett babák? Megszűnő betegségek? Örök élet? – bioetikai kérdések és válaszok.
    Online Cikk. Szeretlek Magyarország, Dinnyés András nyilatkozatával , Hungary, 2. 2021.
  • András Dinnyés: .
    Interjú Dinnyés Andrással a Kossuth Rádió, “Napközben” c. műsorában, Hungary, 1. 2021.

Balázs Enyedi, HCEMM-SU Inflammatory Signaling Research Group

  • Balázs Enyedi: Mechanisms of tissue damage induced inflammation.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 9. 2021.

Prof. Attila Gácser, HCEMM-USZ Fungal Pathogens Research Group

Prof. Lajos Kemény, HCEMM-USZ Skin Research Group

  • Lajos Kemény: Patenting or publishing?.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 12. 2021.
  • András Dinnyés: Interjú Dr. Dinnyés Andrással a Klubrádió “Utópia” c. műsorában, Hungary, 11. 2021.
  • Fanni Balogh: .
    HCEMM – PhD Symposium 2021, Siófok, Hungary, 11. 2021.
  • Máté Manczinger: Big data and personalized medicine. Drug repurposing – two for the price of one..
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Bálint Kintses, HCEMM-BRC Translational Microbiology Research Group

  • Kintses Bálint: Antibiotic resistance.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 9. 2021.
  • Bálint Kintses: Progress report.
    Group Leader – SAP – AFC Meeting 2021, Hungary, 6. 2021.

József Maléth, HCEMM-USZ Molecular Gastroenterology Research Group

  • József Maléth: The inhibition of the mitochondrial Na+/Ca2+ exchanger prevents acinar cell damage in acute pancreatitis in mice.
    Magyar Gasztroenterológiai Társaság 64. Nagygyűlése, Siófok, Hungary, 6. 2022.
  • József Maléth: CFTR activity is determined by the store-independent activation of SPCA2/STIM1/ORAI1 complex in secretory epithelial cells.
    17th ECFS (European Cystic Fibrosis Society) Basic Science Conference, Albufeira, Portugal, 3. 2022.
  • József Maléth : Translational research in gastroenterology.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Karolina Pircs, HCEMM-SU Neurobiology and Neurodegenerative Diseases Research Group

  • Anna Abbas: Studying the effect of Cariprazine in induced neurons directly reprogrammed from Huntington’s disease patient’s fibroblasts.
    HunDoc, Budapest, Hungary, 1. 2023.
  • Karolina Pircs: Stem cells: applications to neuroscience.
    BRIDGE-Translational Excellence Programme, , 9. 2022.
  • Bendegúz Sramkó: The Wisdom in Teeth: Neural differentiation of dental pulp cells.
    National Academy of Sciences audit, Szeged, Hungary, 9. 2022.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , 7. 2022.
  • Karolina Pircs: HCEMM Overview.
    MÉT 84th Annual Meeting – Annual Conference of the Hungarian Society for Microcirculation and Vascular Biology , Budapest, Hungary, 7. 2022.
  • Karolina Pircs: DIRECT NEURAL CONVERSION: NEW POSSIBILITIES TO MODEL LATE-ONSET NEURODEGENERATIVE DISEASES .
    HUPHAR60: Pharmaceutical Research, Innovation and Pharmacokinetics, Mártafüred, Hungary, 6. 2022.
  • Karolina Pircs: Making a transation to a group leader role.
    EMBL Careers Webinars, , 6. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model human ageing and age-related neurodegenerative diseases .
    HCEMM-SZU , Szeged, Hungary, 6. 2022.
  • Karolina Pircs: Distinct subcellular autophagy impairments in induced neurons from Huntington’s disease patients .
    EMBO Autophagy Workshop, Eger, Hungary, 6. 2022.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , 3. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    EMBL-HCEMM Group Leader meeting, Heidelberg, Germany, 3. 2022.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    EMBL-HCEMM Group Leader meeting, Heidelberg, Germany, 3. 2022.
  • Karolina Pircs: MiND+: A new drug screening strategy for age-related cognitive disorders using induced neurons directly reprogrammed from patient’s fibroblasts.
    MultiPark Innovation Talk, Lund, Sweden, 2. 2022.
  • Karolina Pircs: Model-iN.
    Inauguration Ceremony of the Incubator House, Szeged, Hungary, 1. 2022.
  • Karolina Pircs: Model-iN.
    Inauguration Ceremony of the Incubator House, Szeged, Hungary, 1. 2022.
  • Lea Danics: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    HCEMM PhD Symposium, Siófok, Hungary, 11. 2021.
  • Danics Lea: RetaiN: Neuroimmunology and stress resistance _x000B_in human aging and neurodegeneration.
    HCEMM PhD Symposium, Siófok, Hungary, 11. 2021.
  • Karolina Pircs: How to make a great impression? Tricks and hints for the HCEMM Interview presentation.
    HCEMM Junior GL Tranining, Budapest, Hungary, 9. 2021.
  • Karolina Pircs: How to make a great impression? Tricks and hints for the HCEMM Interview presentation.
    HCEMM Junior GL Tranining, Budapest, Hungary, 9. 2021.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    Biological therapies and vaccines: safety issues, physiological and immunological mechanisms (Summer School for PhD students and young researchers), , 6. 2021.
  • Karolina Pircs: Direct neural conversion: New possibilities to model late onset neurodegenerative diseases.
    Biological therapies and vaccines: safety issues, physiological and immunological mechanisms (Summer School for PhD students and young researchers), , 6. 2021.
  • Karolina Pircs: Model-iN.
    Group Leader – SAP – AFC Meeting 2022, Varga tanya, Hungary, 6. 2021.
  • Karolina Pircs: Model-iN.
    HCEMM „Researcher Retreat” , Vargatanya, Hungary, 6. 2021.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , 11. 2020.
  • Karolina Pircs: Bőrsejtből agysejt: Sejtprogramozás alapfokon.
    Researchers Night, , 11. 2020.

Metabolic and Cardiovascular Diseases

László Csanády, HCEMM-SU Molecular Channelopathies Research Group

Eszter Farkas, HCEMM- USZ Cerebral Blood Flow and Metabolism Research Group

Nazha Hamdani, HCEMM-SU Cardiovascular Comorbidities Research Group

Balázs Papp, HCEMM-BRC Metabolic Systems Biology Research Group

  • Eszter Ari: Global map of evolutionary dependencies between antibiotic resistance and virulence genes in E. coli.
    Bioinformatics, Celebrating the Hungarian Science (HAS, Research Centre for Natural Sciences), Budapest, Hungary, 11. 2022.
  • Eszter Ari: Impact of restrictive measures in Hungary on the spread and genetic diversity of SARS-CoV-2 virus.
    BRC-SZAB COVID19 series of scientific lectures, , 11. 2021.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes.
    Researcher’s Night, Budapest, Hungary, 11. 2020.
  • Eszter Ari: Evolutionary study of Hungarian coronavirus genomes.
    Tudományok Fővárosa, Budapest, Hungary, 10. 2020.
  • Roland Tengölics: Accelerated metabolome evolution of S. cerevisiae.
    Darwin Days, Tihany, Hungary, 2. 2020.

Zoltán Varga, HCEMM-SU Cardiometabolic Immunology Research Group

  • Vörös Imre: Pharmacokinetic characteristics of a microRNA mimic after intravenous injection in mice.
    MKT 2023. évi Tudományos Kongresszusa, Balatonfüred, Hungary, 5. 2023.
  • Nabil V. Sayour: Novel druggable targets of heart failure with reduced ejection fraction identified by Next Generation Sequencing and validated by droplet digital PCR .
    28th Kraków Conference on Endothelium and 10th Cardiovascular Research Days, Krakow, Poland, 12. 2022.
  • Tamás Gergely: Molecular characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals IL-17A as a driver of cardiac dysfunction after anti-PD-1 treatment.
    28th Kraków Conference on Endothelium and 10th Cardiovascular Research Days, Krakow, Poland, 12. 2022.
  • Kovács Tamás: The role of melanoma subtypes in immune checkpoint inhibitor related cardiotoxicity – project plans.
    HCEMM PhD – Postdoc Symposium 2022, Egerszalók, Hungary, 11. 2022.
  • Onódi Zsófia: Distinct patterns of inflammasome signalling in the cardiac and skeletal muscle from murine models of Duchenne muscular dystrophy.
    HCEMM retreat 2022, Egerszalók, Hungary, 11. 2022.
  • Onódi Zsófia: Distinct patterns of inflammasome signalling in the cardiac and skeletal muscle from murine models of Duchenne muscular dystrophy.
    IACS, Szeged, Hungary, 9. 2022.
  • Onódi Zsófia: A kardiovaszkuláris kutatásbna alkalmazott sejtvonalak és primer sehtkultúrák összehasonlító vizsgálata.
    HUPHAR 2022, Mátrafüred, Hungary, 6. 2022.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    ISCTICO-HUPHAR-IUPHAR international conference, Pécs, Hungary, 10. 2021.
  • Tamás Gergely: Immune checkpoint inhibition with PD-1 inhibitor induces cardiac dysfunction without overt myocarditis in C57BL/6 mice.
    PhD Days 2021, Budapest, Hungary, 7. 2021.

Nikolett Wohner, HCEMM-SU Thrombosis and Hemostasis Research Group

Lamsa Karri, Human neuron physiology and therapy Core Group

  • Karri Lamsa: It is hard for human fast-spiking neuron to be a fast-spiker.
    University seminar series, Amsterdam Vrije University, Netherlands, 5. 2023.
  • Karri Lamsa: Fascilitated electrical reactivity of human neurons.
    NeuroNex Journal Club, Yale University School of Medicine, USA, 3. 2023.
  • Karri Lamsa: Recording from resected human brain tissue.
    UniQure gene therapy company, Amsterdam Netherlands, 1. 2023.
  • Karri Lamsa: Understanding ‘uniqueness’ of human cortical neurons.
    METT 2022 Physiology meeting, Budapest, Hungary, 6. 2022.

Balazs Németh, HCEMM-USZ Translational Pancreatology Research Group

Genomic Instability and Cancer

Antal Berényi, HCEMM-USZ Magnetotherapeutics Research Group

  • Antal Berenyi: Transzkraniális elektromos stimuláció epilepsziában .
    Mind Clinic Seminars, Budapest, Hungary, 3. 2022.

Csaba Bödör, HCEMM – SU Molecular Oncohematology Research Group

  • Csaba Bödör: Molecular Diagnostics of Chronic Lymphocytic Leukemia State of the art.
    Online educational meeting, Astra-Zeneca, Online , Virtual, 1. 2022.
  • Csaba Bödör: Importance of molecular genetics in oncohematology.
    Scientific meeting organized by the Szeged local committee of the Hungarian Academy of Sciences, Szeged, Hunagary, 3. 2021.

Lajos Haracska, HCEMM-BRC Mutagenesis and Carcinogenesis Research Group

  • Lajos Haracska: Molecular players of rescuing the replication fork stalled at damaged DNA.
    GINOP-2.3.2-15-2016-000024 Closing Conference, Szeged, Hungary, 8. 2022.
  • Lajos Haracska: Replication of damaged DNA.
    HCEMM Group Leader Meeting, Kerekegyháza, Hungary, 6. 2022.
  • Lajos Haracska: Genomic instability and cancer.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, 10. 2021.

Tibor Pankotai, Genome Integrity and DNA Repair Core Group

Máté Manczinger, HCEMM-BRC Systems Immunology Research Group

Lőrinc Sándor Pongor, Cancer genomics and epigenetics

Lajos Vince Kemény, HCEMM-SE Translational Dermatology Research Group

  • Lajos Vince Kemény: Kutatás a bőrgyógyászatban.
    Kutatók éjszakája, Budapest, Hungary, 09. 2022.

Infectious Diseases with special emphasis on Co-Morbidities

Christoph Sensen, Circulating Nucleic Acid Biomarker Research Group

  • Christoph Sensen: Molecular markers.
    „HCEMM PhD course: Translational medicine: from bench to bedside and back again”, Hungary, okt. 2021.

Viktória Lázár, HCEMM-BRC Pharmacodynamic Drug Interaction Research Group

Advances Core Facilities

Ferhan Ayaydin, HCEMM-USZ Functional Cell Biology and Immunology

  • Ferhan Ayaydin: Advanced applications of confocal laser scanning microscopy.
    Advanced fluorescence microscopy techniques in cell biology and tissue culture (As part of course series held in USZ Faculty of Science and Informatics), Szeged, Hungary, apr. 2022.

Zsuzsanna Darula, HCEMM-BRC Single Cell Omics

  • Balogh Gábor: Egysejt lipidomika.
    51. Membrán-transzport konferencia, Sümeg, Hungary, 5. 2022.
  • Gyöngyi Cinege: Horizontally transferred genes are required for an effective innate immune response.
    Straub days, Szeged, Hungary, 5. 2022.
  • Zsuzsanna Darula: The Advanced Core Facility network of HCEMM.
    HCEMM inauguration ceremony, Szeged, Hungary, 1. 2022.
  • Zsuzsanna Darula: The Advanced Core Facility network of HCEMM.
    HCEMM inauguration ceremony, Szeged, Hungary, 1. 2022.
  • Éva Klement: FAIMS – proteomikai alkalmazások.
    MS Szakmai Nap, , 12. 2021.
  • Eszter Farkas: Do microglia contribute to cerebral vasoregulation? .
    EMBO Workshop: Microglia 2021, Heidelberg, Germany, 10. 2021.

Domokos Máthé, HCEMM-SU In Vivo Imaging

  • Domokos Máthé: Copper-64 / Actinium-225-human anti-PSCA-IgG4 theranostics of a prostate cancer model.
    Deutsche Gesellschaft für Nuklearmedizin, Hannover, Germany, 4. 2021.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.

EU Flag

Awards

Consortium

Semmelweis University logo
SZTE logo
BRC logo
National Research, Development and Innovation Office

About HCEMM

Hungarian Centre of Excellence for Molecular Medicine is a strong catalyst of reformative changes in biomedical science and in institutional research management.

National VAT number: 26307383-2-06
EU VAT number: HU26307383

Linkedin Facebook Twitter Instagram
kozadattar logo

Internal Policies

Contact Info

Copyright © 2023 Hungarian Centre of Excellence for Molecular Medicine, all rights reserved. Hungarian Centre of Excellence for Molecular Medicine® and HCEMM® are registered trademarks of the the HCEMM Nonprofit Ltd.
This website uses cookies. For more information visit the Cookies & Privacy Policy page.
ACCEPT
Skip to content